J. North

发表

Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.

P. Moscato, D. Joseph, N. Spry, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

C. D’Este, D. Joseph, N. Spry, 2011, The Lancet. Oncology.

The pre‐operative identification of low‐risk endometrial cancer: an audit of women treated in the South Island of New Zealand 1998–2000

J. North, P. Sykes, N. Anderson, 2002, The Australian & New Zealand journal of obstetrics & gynaecology.

Stereotactic Ablative Radiotherapy for Inoperable Early Stage Non-small Cell Lung Cancer - Dunedin Experience

J. North, S. Costello, M. A. Rahim, 2013 .

A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus

V. Gebski, P. Devitt, D. Joseph, 2002 .

Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer.

D. Joseph, N. Spry, J. Denham, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation-induced osteonecrosis of the hips following genital-preserving surgery and chemoradiotherapy.

J. Quinlan, J. North, D. Gwynne-Jones, 2009, The New Zealand medical journal.

Painful ophthalmoplegia following treated squamous carcinoma of the forehead. Orbital apex involvement from centripetal spread via the supraorbital nerve.

W. Hoyt, J. North, C. Moore, 1976, The Medical journal of Australia.

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

C. D’Este, D. Joseph, H. Mameghan, 2005, The Lancet. Oncology.

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

V. Gebski, R. Simes, R. Simes, 2005, The Lancet. Oncology.

Primary breast cancer of the vulva: Case report and literature review

J. North, M. Pearse, A. Dempster, 2007, The Australian & New Zealand journal of obstetrics & gynaecology.

Survival after CPR in very-low-birth-weight infants.

T. Raju, S. Miles, C. Stocking, 1988, The New England journal of medicine.

A quality assurance audit: phase III trial of maximal androgen deprivation in prostate cancer (TROG 96.01).

D. Joseph, H. Mameghan, N. Spry, 2000, Australasian radiology.

Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.

C. D’Este, D. Joseph, H. Mameghan, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer.

D. Joseph, H. Mameghan, N. Spry, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SU‐GG‐T‐427: Dose Painting to Combat Tumor Hypoxia While Sparing Urethra in Prostate IMRT: A Biologically‐Based Adaptive Approach Accounting for Setup Uncertainties and Organ Motion

Vitali Moiseenko, J North, Karl Otto, 2008 .

496 oral IMPORTANT MORTALITY REDUCTIONS BY SHORT TERM ANDROGEN DEPRIVATION AND RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER: 10 YEAR TRIAL DATA FROM TROG 96.01

C. D’Este, D. Joseph, N. Spry, 2011 .

Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial

D. Joseph, N. Spry, J. Denham, 2012, Prostate cancer.